Organ Preservation Market - Global Opportunity Analysis, 2025

f:id:RupeshD:20180117211115p:plain

Organ preservation involves removal of organs from the bodies, which are then stored for transplantation. Organ preservation systems are exclusively prepared and maintained according to the biological environment (temperature and oxygen) needed to store particular organs. Different body organs require specific and suitable storage conditions to maintain their anatomical and physiological processes. Important parameters in organ preservation include delivering of high quality organs to the donors, matching the patient and organ suitability, and restart of life of the organs and sustaining functions after the transplantation. Organ transplantation process starts with removing the needed organ from the donor body, then the organ is stored and transported. The conditions of the organs are maintained in its natural state and functioning by avoiding any significant damage. Organ is preserved thoroughly till it is transplanted into the patient’s body. The most suitable temperature for preservation is between 4°C to 8°C, which significantly reduces the metabolic rate of the organ.

Access Table of Content (TOC) Of the Report: https://www.coherentmarketinsights.com/ongoing-insight/toc/1072

Organ transplantation procedure has evolved with increased procedural feasibility and better understanding of immunity system and reasons behind organ rejection has allowed for improved matching rates for organs and patients after transplants. Enhancement in surgical techniques along with networking of organ donor has saved many lives, owing to improvement of transplantation procedures.

Increasing demand for organ transplants is expected to fuel growth of organ preservation market

According to Organ Procurement and Transplantation Network (OPTN), in 2017, over 117,000 people are in the waiting list of national organ transplant and only around 17,155 organs are transplanted in the year.

Moreover, according to National Kidney Foundation, in 2016, around 121,678 people are waiting for lifesaving organ transplants in the U.S., among which, around 100,791 people are waiting for kidney transplants.

Moreover, many innovative techniques are promising such as normo, sub-normo and hypothermic perfusion technologies, hypothermic surgery and gas persufflation. Furthermore, potential organ preservation techniques such as Organ Bioengineering and Organ Banking are unique and scalable opportunities.

Significant gap between supply and demand and low donation rates are the factors restraining growth of the market.

Advancement in technology and enhancement in techniques are expected to fuel growth of the organ preservation market

Tissue preservation is getting easier due to rapid advancement in technology and can greatly effect by improved matching of donor organ and receiver with reduced organ rejection rates, limiting organ discard, increasing donor utilization, reducing costs such associated with short-notice plane and helicopter transportation. Adult-derived stem cells such as mesenchymal stem cells (MSCs) offer great therapeutic promise for numerous clinical applications. MSCs can be taken from any tissue in the body that is capable of healing bone marrow, dental pulp, blood, adipose, liver, brain, pancreas, and placenta.

Organ Preservation Market Taxonomy:

On the basis of preservation type, the global organ preservation market is segmented into:

  • Static

    • Static Cold Storage

  • Dynamic

    • Hypothermic Machine Perfusion

    • Normothermic Machine Perfusion

    • Oxygen Persufflation

On the basis of solution type, the global organ preservation market is segmented into:

  • Collins Solution

  • Citrate Solutions

  • University Of Wisconsin Solution

  • Custodiol HTK Solution

  • Celsior Solution

On the basis of organ type, the global organ preservation market is segmented into:

  • Kidneys

  • Liver

  • Lung

  • Heart

  • Others (Intestine & Pancreas)

Regional growth engines of organ preservation market

Regional segmentation of the organ preservation market by Coherent Market Insights comprises, North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America market is expected to hold a dominant position in the global organ preservation market. This is mainly due of better organ preservation facilities, research and development, and skilled professionals in the region. Moreover, increasing geriatric population, as they are more prone to chronic diseases, further augments growth of the market. Asia Pacific region is expected to witness highest growth rate in the market, owing to increasing customer base, increasing organ donation awareness, and increasing healthcare expenditure. Furthermore, low cost and availability of technology, increasing transplant surgeries, and increasing organ donation awareness are the few factors fueling growth of the market in the region. For instance, around 220,000 people had shown interest in post-mortem organ donation, according to a registry held by China Organ Transplant Development Foundation (COTDF), in 2016, owing to various awareness programs held by the organization. Indian government has initiated an organ donation awareness programs such as Organ Donation Day and National Organ & Tissue Transplant Organization (NOTTO), owing to wide adoption of organ donation activities in India.

Key players in the organ preservation market

Key players operating in the global organ preservation market include Teva Pharmaceutical Industries Ltd., Dr. Franz Köhler Chemie GmbH, BioLife Solutions, XVIVO Perfusion AB, Bristol-Myers Squibb, Inc., and ToleroTech, Inc., Lifeline Scientific, Preservation Solutions Inc., and Claris Injectables Limited. Moreover, in 2015, Dr. Franz Köhler Chemie GmbH, opened a new manufacturing site for Custodiol, the market leading organ protective solution of the company.

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Visit our news Website: http://www.coherentnews.com

Vaccines Delivery Devices Market - Global Opportunity Analysis, 2025

f:id:RupeshD:20180117200923p:plain

Vaccines are biological substance that protect humans from infections caused by bacteria and viruses. The different types of vaccines include live/attenuated vaccine, inactivated/killed vaccine, toxoid vaccine, and conjugate vaccine. Vaccines are administered through subcutaneous or intramuscular routes using a syringe or needle.  Needle free technologies are one of the novel vaccine delivery technologies as they are effectively used in mass immunization programmes, thereby reducing the chances of needle stick injuries and the complications associated with the multiple use of single needle. Moreover, other vaccine delivery devices include disposable syringes, jet injectors, micro- needles, and intradermal delivery devices for delivery of inactivated poliovirus vaccine.

Rise in the adoption of needle free technology is expected to augment the growth of vaccine delivery devices market

The major factors contributing to the growth of vaccines delivery devices market are needle free delivery systems, as these systems have potential to decrease the dose of the vaccine antigen and also enhances the vaccine immunogenicity. Rapid advancement of technology in systematic delivery of vaccines such as micro-needles and electroporation, is expected to augment the growth of vaccines delivery devices market. Increasing use of micro-needles is attributed to the demand for the painless self-administration by the patients. Vaccines delivered through micro-needles into the dermis affects faster than the intra-muscular injections, augments the market growth. However, one of the major factors restraining the market growth is the cost of the micro-needles especially in the emerging countries.

Vaccine Delivery Devices Market Taxonomy

Vaccine delivery devices market can be segmented on the basis of product type, route of administration, end user and geography.

On the basis of product type, the global vaccine delivery devices market is segmented into

  • Syringes

  • Jet Injectors

  • Micro needles

  • Aerosol/dry powder inhalation

  • Intranasal delivery devices

  • Intradermal delivery devices

On the basis of route of administration, the global vaccine delivery devices market is segmented into

  • Intradermal

  • Intramuscular

  • Subcutaneous

  • Others

On the basis of end user, the global vaccine delivery devices market is segmented into

  • Hospitals

  • Clinics

  • Others

Access Table of Content (TOC) Of the Report: https://www.coherentmarketinsights.com/ongoing-insight/toc/903

On the basis of geography, the global vaccine delivery devices markets can be segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global vaccine delivery devices, owing to the rising demand of intranasal delivery devices, which offers non-invasive route of administration as compared to injections. Thus, intranasal delivery devices increases the potential for patient compliance and creates a platform for the improvement in pharmacokinetics profiles. Moreover, rapid growth in immunization coverage due to financial support from the Bill & Melinda Gates Foundation and others in 2010, made vaccine available to millions of people in U.S. Furthermore, Asia Pacific is expected to be the key market for the vaccine delivery devices market over the forecast period, due to rising awareness regarding jet injector devices, which has reduced the high risk of cross contamination, needle stick injuries, and is less painful for the patient.

Innovation of hollow microstructured transdermal system, is expected to fuel the market growth

Some of the major players operating in the global vaccines delivery devices market include Panacea Pharmaceuticals, 3 M, Biojet Medical Technologies Pharmajet, Valeritas, Vaxxas, Gerresheimer, Schott AG, Corium International, and Becton Dickinson & Company. Various strategies are adopted by the key players to sustain their position in the market include product development, innovation, mergers and acquisition. For instance, 3M involved in the vaccines delivery devices market recently launched a new drug delivery device named 3M Hollow Microstructured transdermal System (hMts). This device directly delivers the vaccine to the patient’s dermis, which would give rise to the stronger immune response than traditional intramuscular injections. Also, hMTS facilitate consistent and reproducible delivery of the drug. Furthermore, 3M company has collaborated with Panacea Pharmaceuticals in administering therapeutic cancer vaccine directly to the dermis through hMTS.

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Visit our news Website: http://www.coherentnews.com

Telehealth Market - Global Trends, 2017-2025

f:id:RupeshD:20180117185136p:plain

Increasing prevalence of chronic disease with rising healthcare expenditures and high adoption of health IT infrastructure to support telehealth initiatives are also expected to further boost growth of the telehealth market. Veterans Health Administration (VHA) - the largest integrated health care system in the U.S. uses multiple types of telehealth interventions, which provides both routine and targeted care management services. The 2017 finding from Centers for Medicare and Medicaid Services (CMS), stated that telehealth and telemedicine payments increased by 28% and claims increased by 33% in 2016, over the year 2015.

According to the 2017 U.S. Telemedicine Industry Benchmark Survey conducted among healthcare executives, physicians, nurses, and other healthcare professionals throughout the U.S., it was observed that over half of survey participants noted telemedicine as a top priority or high priority service in their respective organizations. Moreover, study findings also show that telemedicine continues to evolve from a specialty service to a mainstream service. Telehealth is a telecommunication technology, which is also referred to as e-Health or telemedicine. It enables healthcare professionals to evaluate, diagnose, and treat patients in remote locations. According to the 2016 E-health and Telemedicine report by the U.S. Department of Health and Human Services, it revealed that 59 million Americans are living in Health Professional Shortage Area (HPSAs)-rural and urban areas with shortages of primary care providers.

Telehealth helps in improving relationship between patients and healthcare provider for enhanced patient care and satisfaction. Telehealth provides medical expertise in quick and convenient manner, and at reduced cost. Using telehealth, healthcare professionals can advise patients at their homes and workplaces. Physicians can also treat their patients from hospitals, medical facilities or from other places of work including their own homes or even during vacation as long as they are connected through the Internet.

Increasing number of geriatric population, higher incidences of non-communicable disease such as cardiovascular disease, metabolic disorders, Alzheimer’s disease, cancer, diabetics, and other mental health problems which require prolonged treatment would aid in growth of the telehealth market in near future. The nature of most non-communicable disease (NCDs) requires well-integrated healthcare system to treat chronic healthcare conditions. Moreover the challenges faced to meet required healthcare professionals, financial and infrastructure resources further can be addressed effectively through telehealth market. The 2016 Physician Supply and Demand Report, released by Association of American Medical College (AAMC), projects the significant physician shortfall in the U.S. between 2014 and 2025, in the range of 61,700 to 94,700.

Access Table of Content (TOC) Of the Report: https://www.coherentmarketinsights.com/ongoing-insight/toc/1020

Iincreasing prevalence of chronic disease with rising healthcare expenditures and high adoption of health IT infrastructure to support telehealth initiatives are also expected to further boost growth of the telehealth market. Veterans Health Administration (VHA) - the largest integrated health care system in the U.S. uses multiple types of telehealth interventions, which provides both routine and targeted care management services. The 2017 finding from Centers for Medicare and Medicaid Services (CMS), stated that telehealth and telemedicine payments increased by 28% and claims increased by 33% in 2016, over the year 2015.

However, lack of trained professionals in remote areas, privacy and information security concerns, and low availability of telecommunication bandwidth are the major factors adversely affecting growth of the telehealth market. 

According to the 2016 Broadband Progress Report from Federal Communications Commission, around 40% of rural Americans still lack access to broadband Internet. Furthermore, according to the 5G Readiness Survey 2017, by Ericsson AB, 78% respondents of IT decision makers from all major verticals including healthcare have accelerated their plans to incorporate 5G into their IT infrastructure.

Increased adaptation of telehealth will significantly decrease the dependency on hospitals, and enable accessibility to proper healthcare services from home. A report published in March 2017, by NTCA-The Rural Broadband Association stated that, telemedicine could save thousand dollars per year in healthcare and community costs, thereby, reducing significant cost spent on transportation, medical facility, labor wages, and lab cost.   

Telehealth market Taxonomy:

On the basis of component, the global telehealth market is segmented into:

  • Hardware

  • Software

  • Services

On the basis of mode of delivery type, the global telehealth market is segmented into:

  • On-premise

  • Cloud based

On the basis of end-user, the global telehealth market is segmented into:

  • Telehealth Providers

  • Patients

  • Other end-users

Government initiatives aid in boosting growth of the telehealth market

The new CONNECT (Creating Opportunities Now for Necessary and Effective Care Technologies) for Health Act, introduced in June 2017, will promote cost savings and improve quality care in Medicare through telehealth and remote patient monitoring, in the U.S. The new act will provide efficient healthcare services to Medicare beneficiaries through telemedicine and remote patient monitoring (RPM). In addition, the act permits the use of remote patient monitoring for patients suffering with chronic conditions. In 2017, Southwest Telehealth Resource Center (SWTRC), received US$ 975,000 cooperative agreement grant from the Federal Office for the Advancement of Telehealth (OAT). Such grants will help in adoption of telehealth programs in hospitals, clinic, and public health offices in the underserved areas in the U.S.

Click here to know more about this report: https://www.coherentmarketinsights.com/ongoing-insight/telehealth-market-1020

Key players in the telehealth market

Some of the key players operating in the telehealth market include Koninklijke Philips N.V., Medtronic plc, Tunstall Healthcare Group Ltd, McKesson Corporation, Medvivo Group Ltd., AMD Global Telemedicine, Inc., Vidyo, Inc., Cisco Systems, Inc., Care Innovations, LLC, Honeywell Life Care Solutions, and General Electric Company.

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Visit our news Website: http://www.coherentnews.com



 

Advanced Therapy Medicinal Products Market - Global Opportunity Analysis, Trends - 2025

f:id:RupeshD:20180117174137p:plain

Rising incidences of Alzheimer’s is expected to foster the growth of advanced therapy medicinal products market

The factors that are contributing the growth of advanced therapy medicinal products market are rising prevalence of Alzheimer’s disease. According to Alzheimer’s disease International in 2017, around 50 million people were estimated to suffer from Alzheimer’s disease across the globe. Furthermore, rising demand for gene therapies used in the treatment of ocular, neurodegenerative diseases, and several cancers accompanied by technological advancements in genetic engineering tool such as RNAi  are the factors that are expected to boost the growth of advanced therapy medicinal products market. However, the factors that are hindering the growth of advanced medicinal therapy products market are inadequate transparency, lack of funds, and regulatory guidance for biopharmaceutical companies to manufacture these therapies and products.

Access Table of Content (TOC) Of the Report: https://www.coherentmarketinsights.com/ongoing-insight/toc/1101

Advanced Therapy Medicinal Products (ATMPs) are innovative therapies that comprises cell therapy, gene therapy, and tissue engineered products. Cell therapy products include cellular immunotherapies and autologous and allogeneic cells for certain therapeutic indications including adult and embryonic stem cells. Whereas, Human gene therapy refers to products that introduce genetic material into individuals DNA to replace faulty or missing genetic material, thus treating a disease or abnormal medical condition. These are a novel class of medicines that offer potential treatment opportunities for diseases that have currently limited or no therapeutic options such as hemophilia, cystic fibrosis, metabolic disorders, muscular dystrophies, skin burns, Alzheimer, and cancer. Although majority of ATMPs are in an early stage of development, consolidated trial stage and the chances to cure chronic conditions signify that ATMPs may achieve the market sooner than standard treatments. Furthermore, advanced therapy medicinal products are regulated and authorized for marketing by the Food and Drug Administration (FDA) in the U.S. and by European Medicines Agency (EMA) in the Europe.

Advanced Therapy Medicinal Products Market Taxonomy:

Advanced therapy medicinal products are segmented on the basis of therapy, diseases, and geography

On the basis of products, the global advanced therapy medicinal products market are segmented into:

  • Somatic Cell Therapy Medicinal Products

  • Tissue Engineered Medicinal Products

  • Gene Therapy Medicinal Products

On the basis of diseases, the global advanced therapy medicinal products market are segmented into:

  • Alzheimer’s

  • Cystic Fibrosis

  • Muscular Dystrophies

  • Hemophilia

On the basis of geography, the global advanced medicinal therapy products are segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global advanced medicinal therapy products market, owing to the development in the field of cell and gene therapy. For instance, the innovative gene therapy known as CAR-T or chimeric antigen receptor T-cell therapy harnesses the body’s own immune cells to recognize and attack malignant cells. The T-cells are harvested and modified with a new gene. The new gene contains a protein that directs the T-cells to target and kill leukemia cells that have a specific antigen on the surface. Moreover, Food and Drug Administration (FDA) approved first gene therapy in the U.S. in 2017, leading a new approach to the treatment of cancer and other serious and life-threatening diseases.  Moreover, Kymriah a cell based gene therapy has also been approved by FDA in 2017 in the U.S. for the treatment of patients with a form of acute lymphoblastic leukemia. Furthermore, Asia Pacific is expected to be the fastest growing region for the global advanced therapy medicinal products market mainly due to rising number of skin burns cases and cancer diseases.

Strategic acquisitions by Pfizer to develop gene therapies for the treatment of neuromuscular conditions to enhance the competitive environment

The key players operating the advanced therapy medicinal products market include Uniqure, Pfizer, Bluebird Bio Inc., BioMarin Pharmaceutical, Novartis AG, GE Healthcare, Shire Biotechnology, and Kite Pharma. The key players are focusing on strategic mergers and acquisition and development of innovative products. For instance, Pfizer acquired Bamboo Therapeutics, a biotechnology company focused on developing gene therapies for the treatment of patients with diseases related to neuromuscular conditions and the diseases affecting central nervous system. The acquisition is expected to significantly expand Pfizer’s expertise in gene therapy by providing clinical and pre-clinical assets to balance the rare disease portfolio of company with advanced recombinant Adeno Associated Virus vector design and production technology, which is fully functional phase I/II gene therapy with manufacturing facilities.

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Visit our news Website: http://www.coherentnews.com

Global Sports Medicine Market - Global Trends, 2025

Rise in incidence of sport related injuries will augment the market growth

Increasing cases of bone fractures, trauma due to fall, and others, require medical intervention (orthopedics), thus, augmenting the need for sports medicine products. In 2012, according to the National Institute of Health, knee is the most commonly injured joint by adolescent athletes with an estimated 2.5 million sports-related injuries presenting to emergency departments, annually in the U.S. This number is expected to increase significantly over the forecast period. Increasing adoption of minimally invasive techniques by healthcare professionals owing to long-term benefits of this surgery is also expected to propel growth of the sports medicine market. Minimally invasive surgeries such as arthroscopy of the knees, shoulders, elbows and ankles has become the standard method for care. However, lack of skilled professionals in this field and high costs associated with the devices may hamper growth of the sports medicine market.

The global sports medicine market is expected to be valued at US$ 7,308.24 million in 2017 and is expected to witness a CAGR of 7.6% over the forecast period (2017 – 2025).

Sports medicine is the treatment and prevention of sports related injuries. These injuries include strain, sprain, musculoskeletal injuries, soft tissue damage joint dislocation, and fractures. Increasing participation in various sports, globally is expected to fuel adoption of sports medicine over the forecast period. The field of sports medicine has a wide variety of disciplines, from physiotherapy and orthopedics, to public health and psychiatry. It aids in enhancing the physical fitness and overall performance of the athletes.

New product launches by manufacturers is a prominent factor fueling market growth

Manufacturers are focusing on introducing cost-effective and wear- reducing quality products in order to enhance their product offerings and increase market share. For instance, in September 2017, Smith and Nephew partnered with Imperial College London to develop enhanced surgical techniques relating to ligament function, biomechanics, and soft tissue injuries of the knee, including the most common injuries of torn menisci and anterior cruciate ligament rupture.

North America accounted for the largest market share, followed by Europe in 2016, owing to rise in number of osteoporotic fractures in the U.S. and high adoption of technology such as computer-assisted and robotic-assisted surgeries in the medical settings, providing precision, and accuracy in the sports related injuries. For instance, according to the National Osteoporosis Foundation (NOF), over 1.3 million osteoporotic fractures occur each year in the U.S. The market in Asia Pacific is also expected to witness substantial growth. This is owing to increasing government and private initiatives to create awareness about the healthy living and rise in medical tourism. Ministry of Health (MOH), Singapore and Health Promotion Board (HPB) have set up programmes such as Lose to Win, STEP (Strength Training Exercise Programme), and OPTIMAL (Osteoporosis Patient Targeted and Integrated Management for Active Living Programme) to promote healthy lifestyle in the community in order to minimize the risk of developing bone and cartilage disorders.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1116

Competitors in the sports medicine market are focused on new product development to enhance is market share. For instance, in July 2015, Mitek Sports Medicine — part of DePuy Synthes Companies of Johnson & Johnson — introduced two new arthroscopic surgery radiofrequency devices, The VAPR TRIPOLAR 90 Suction Electrode and the VAPR ARCTIC Suction Electrode, to enhance soft tissue ablation and coagulation during arthroscopy surgery.

Some of the key players in sports medicine market are Zimmer Biomet, Smith & Nephew Plc, Johnson & Johnson, Breg, Inc., Wright Medical Group N.V., Medtronic Plc, Stryker Corporation, Mueller Sports Medicine, Inc., DJO, LLC, Conmed Corporation, and RTI Surgical, Inc.

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Visit our news Website: http://www.coherentnews.com

Ethanol Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

Ethanol Market Overview

Ethanol, commonly known as ethyl alcohol or grain alcohol, is a colorless liquid manufactured from starch-based, sugar-based or cellulosic feedstock. The U.S. and Brazil are the major producers of ethanol. Corn is the major feedstock used in the production of ethanol in the U.S., while ethanol is produced from sugarcane in Brazil. According to Renewable Fuels Association (RFA), 25,576 million gallons of fuel ethanol was produced in 2015. According to Sucres & Denrées (Paris), approximately 110 billion litres of ethanol is consumed globally each year. Ethanol has wide range of applications such as biofuel, industrial, food & beverages, pharmaceuticals, and cosmetics. Approximately 87% of the global ethanol is used in producing biofuels. The environmental concerns related to greenhouse emissions have resulted in use of ethanol to produce transport fuels. The U.S., Brazil, and Europe are the major producers and consumers of ethanol. According to RFA, the gross output of ethanol industry in the U.S. was US$ 23.33 billion in 2016. Growth of ethanol market in Asia Pacific is attributed to increasing consumption of biofuels. According to International Energy Agency, the biofuel market in road transport application is estimated to expand at a CAGR of 3.9% by 2020. This in turn is projected to fuel growth of the ethanol market.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/276

Global Ethanol Market Taxonomy

The global ethanol market is classified on the basis of the following segments:

Process

Wet-milling

Dry-milling

Product Type

Synthetic ethanol

Oil derivatives

Coal

Others

Agricultural ethanol

Sugarcane

Sugarbeet

Maize

Wheat

Rye

Others

 Application

Fuels

Industrial

Pharmaceutical

Food & beverages

Cosmetics

Others

Have a doubt? Speak to our analyst now! https://www.coherentmarketinsights.com/insight/talk-to-analyst/276

Prevalent Scenario in Ethanol Market

Increased applications of ethanol in biofuels, industrial, pharmaceuticals, cosmetics, and food & beverages sectors lead to burgeoning growth of the ethanol market. According to Independent Chemical Information Service (ICIS), 73% of ethanol is used as fuel, 17% in beverages and 10% of ethanol is used for industrial applications. Increasing demand of biofuels is fueling growth in consumption of ethanol in the renewable fuel energy sector. According to State Council General Research Office, the U.S. government is promoting use of ethanol as a source of renewable fuel and creating awareness regarding the environmental and social benefits of gasoline. Corn, sugarcane, grains, sugarbeet are common sources for manufacturing agricultural ethanol. Ethanol used for in fuel applications are agricultural ethanol as synthetic ethanol is not used for fuel applications. Ethanol is used as solvents in industrial applications for wide range of end users which include cosmetics, detergents and cleaning products, printing ink, paint & coatings. Ethanol has its application in food & beverage sector in manufacturing vinegar, alcoholic beverages, and is also used as glazing agents in bakery & confectionery.

Government initiatives play a vital role in development and innovation of ethanol for wide range of applications. For instance, the fuel regulations imposed by the government in Mexico allowed 5.8% of ethanol blends in the fuel supply. The government and ethanol associations are continuously working in coordination to fuel the growth of ethanol market. RFA in partnership with federal government and the industry key players are working to innovate new applications of ethanol and minimize the difficulties related to trade of ethanol and enhance the market growth globally. U.S. and Brazil contributes a major market share in production and consumption of ethanol. Asia-Pacific market is expected to grow due to growing applications of ethanol industrial chemicals to manufacture acetic acid and ethyl acetate and the increasing applications of ethanol as solvents in pharmaceutical and cosmetic sectors.

Click here to know more about this report: https://www.coherentmarketinsights.com/ongoing-insight/ethanol-market-276

Fragmented Market

The global ethanol market is highly fragmented due to the participation of many established and emerging players in the ethanol industry. Major players involved in the market include Archer Daniels Midland Company (U.S.), Cargill, Inc. (U.S.), Grain Processing Corporation (U.S.), Ace Ethanol LLC (USA), Advanced BioEnergy, LLC (USA), Chemtex Group (USA), MGP Ingredients (U.S.), Flint Hills Resources LP (USA), Copersucar SA (Brazil), Adkins Energy LLC (USA).

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #320000A0
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

 

Liquid Packaging Market - Global Industry Insights, Trends, and Opportunity Analysis, 2016–2024

Liquid packaging is a packaging technology that is used to protect consumables such as food and liquids from contamination and damage during transport and storage. Liquid packaging helps in maintaining the freshness of the product, and plays a vital role in protecting the product from moisture. Also, it helps the product in improving the scuff, resistance to tear, and puncture resistance. Liquids and food products need to be packaged in tough materials with good seal integrity to avoid leakage, cracking, and degradation during transportation. Liquid and food products include dairy products, syrups, water, cooking oil, fruit juices, shampoos, grease, and motor oil. Liquid packaging offer better shell life, high recyclability, eco-friendliness, and are convenient to transport.

Various techniques such as aseptic liquid packaging, blow molding, and form fill seal technology are used to process liquid packaging materials.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/273

Liquid Packaging Market Taxonomy

On the basis of type of technique, the global market is segmented into:

Aseptic Liquid Packaging

Blow Molding

Form Fill Seal Technology

On the basis of Resins types, the global market is segmented into:

Low Density Polyethylene (LDPE)

High Density Polyethylene (HDPE)

Polypropylene

Polyethylene Terephthalate (PET)

Others

On the basis of Packaging types, the global market is segmented into:

Flexible Liquid Packaging

Films

Stand-Up Pouches

Bag-In-Box

Others

Rigid Liquid Packaging

Cartons

Brick Carton

Gable Top Carton

Shaped Carton

Paperboard

Plastics & PET Bottles

Glass

Cans

Others

On the basis of application, the global materials market is segmented into:

 Food & Beverages

Dairy Products

Milk and Yogurt

Buttermilk

Others

Wine & Spirits

Juice & Drinks

Drinking Water

Fruit Juice

Tea

Coconut water

Carbonated Soft Drinks

Tomato Sauce

Others

Medical & Pharmaceutical

Cosmetics & Personal Care

Household

Industrial

Others

Have a doubt? Speak to our analyst now! https://www.coherentmarketinsights.com/insight/talk-to-analyst/273

Aseptic liquid packaging technique is the most widely used packaging technique. These types of packing are usually made of paperboards containing thin layers of aluminum and plastics. This packaging helps preserve food for long time without the need to add preservatives. Rigid liquid packaging type is extensively used in liquid packaging. It includes paperboard, cartons, cans, and PET bottles. Plastics & PET bottles are widely used in packaging of food & liquid products such as carbonated drinks, water, beverages, dairy products, and alcohol. Food & beverages is the largest end-use industry in liquid packaging market. This is due to the rising population in Asia-Pacific region, and rising disposable incomes in emerging economies such as Brazil, Mexico, China, and India.  Rising consumption of packaged food in North America and Europe region is also the key factor driving the global liquid packaging market.

Liquid Packaging Market Outlook – Asia-Pacific is the largest, and fastest-growing region, globally

Asia-Pacific is the largest and fastest-growing region in the global liquid packaging market. According to EUSME Center— a European Union initiative that provides a comprehensive range of hands-on support services to European small and medium-sized enterprises (SMEs), getting them ready to do business in China—China continues to be the world’s largest consumer market for food and beverage (F&B) products, surpassing the U.S. in 2011. In 2015, food & beverages exports from Europe to China increased by 48%. In 2014, exports of dairy products from Europe grew by 11%. Growth of imported food & beverages products is driven by limited arable land, rising disposable income, water scarcity issues, improving logistics systems, increasing urbanization, and growing concerns for food safety. This in turn fuels growth of the liquid packaging market in Asia Pacific. In 2015, the Indian food processing industry accounts for 32% of the country’s total food market, and is one of the largest industries in India and is ranked fifth in terms of production, consumption, export and expected growth. It contributes around 14% of manufacturing Gross Domestic Product (GDP), 13% of India’s exports and 6% of total industrial investment. Indian food service industry is expected to reach US$ 78 billion by 2018. India's organic food market is expected to increase three times by 2020, as compared to 2015. Hence, there is a large demand for liquid packaging materials in Asia Pacific region, making it the largest and fastest-growing market for liquid packaging.

Click here to know more about this report: https://www.coherentmarketinsights.com/ongoing-insight/liquid-packaging-market-273

Some of the major companies operating in the global liquid packaging materials market are The Dow Chemical Company, Smurfit Kappa, International Paper, Tetra Pak International S.A., Nippon Paper Industries Co., Ltd, Liqui-Box Corporation, Tri-Wall Limited, Evergreen Packaging, Elopak Group, BillerudKorsnas AB and Mondi Plc.

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:
sales@coherentmarketinsights.com